154 related articles for article (PubMed ID: 2694093)
1. Class II alloantigen expression on leukemic cells.
Falkenrodt A; Urlacher A; Mayer S; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard S; Mitsuichi Y; Dormoy A
Nouv Rev Fr Hematol (1978); 1989; 31(3):209-16. PubMed ID: 2694093
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
5. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
6. [Expression of class I and class II markers on populations of leukemic cells].
Tongio MM; Falkenrodt A; Urlacher A; Mitsuishi Y; Bergerat JP; Boilletot A; Lutz P; Griveau AM; Troussard X; Mayer S
Pathol Biol (Paris); 1986 Jun; 34(6):753-7. PubMed ID: 3531991
[TBL] [Abstract][Full Text] [Related]
7. Distribution of class IIDQ antigens on normal and leukemic lymphoid cells.
Fermand JP; Schmitt C; Brouet JC
Eur J Immunol; 1985 Dec; 15(12):1183-7. PubMed ID: 3878788
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
[TBL] [Abstract][Full Text] [Related]
10. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
[TBL] [Abstract][Full Text] [Related]
11. Purine metabolism enzymes and immunological phenotype in chronic B-cell malignancies: chronic lymphocytic leukemia, prolymphocytic leukemia and hairy cell leukemia.
Babusíková O; Hrivnáková A; Klobusická M; Mesárosová A; Ujházy P
Neoplasma; 1990; 37(6):693-701. PubMed ID: 2125699
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
[TBL] [Abstract][Full Text] [Related]
13. Deficient expression of MHC class II antigens in some cases of human B cell leukaemia.
Guy K; Docherty LJ; Dewar AE
Clin Exp Immunol; 1986 Feb; 63(2):290-7. PubMed ID: 3486060
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
15. Ontogenic and functional implications of the differential expression of HLA-DQ antigens on leukemic cells.
Navarrete C; Fernandez N; Alonso MC; Festenstein H
Hum Immunol; 1986 May; 16(1):52-68. PubMed ID: 3519548
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies against MHC class II antigens elicited with a human non-T, non-B acute lymphoblastic leukemia cell line.
Poláková K; Chorváth B; Sedlák J; Duraj J; Matoska J; Karpatová M
Neoplasma; 1985; 32(6):641-8. PubMed ID: 3911080
[TBL] [Abstract][Full Text] [Related]
17. [ICO-1 monoclonal antibodies against the constant region of Ia-like (Dr) antigens].
Baryshnikov AIu; Blokhina NG; Kadagidze ZG; Novikov VV; Trofimova MN
Eksp Onkol; 1984; 6(4):44-6. PubMed ID: 6389089
[TBL] [Abstract][Full Text] [Related]
18. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
19. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
[TBL] [Abstract][Full Text] [Related]
20. Recognition of leukemic blasts by HLA-DPB1-specific cytotoxic T cell clones: a perspective for adjuvant immunotherapy post-bone marrow transplantation.
Ibisch C; Gallot G; Vivien R; Diez E; Jotereau F; Garand R; Vié H
Bone Marrow Transplant; 1999 Jun; 23(11):1153-9. PubMed ID: 10382955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
